Top-News

PharmaCyte Biotech News

Keine aktuellen Kursdaten verfügbar
WKN: A12HVG
ISIN: US71715X1046
Typ: Aktie

PharmaCyte Biotech News

06.02.20 - Newsfile
PharmaCyte Biotech Exploits Potential Of Its Cell-in-a-Box(R) Technology; Targets Billion Dollar Cancer, Diabetes, and Medicinal Cannabinoid Markets
Soulstring Media Group covers how this emerging biotech can become a potential leader in treating pancreatic cancer and diabetes with its Cell-​in-a-Box(R) technology
31.05.16 - PR Newswire
OTCQX and OTCQB Companies to Present at 2016 Marcum MicroCap Conference
OTCQX and OTCQB Companies to Present at 2016 Marcum MicroCap Conference OTC Markets Group, President and CEO R. Cromwell Coulson, will speak on panel ...
31.12.15 - PR Newswire
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of PharmaCyte Biotech, Inc. (OTCMKTS: PMCB)
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of PharmaCyte Biotech, Inc. (OTCMKTS: PMCB) PR Newswire
12.11.15 - PR Newswire
Broad Street Alerts - PharmaCyte Biotech Investor Update: Revolutionizing Potential Diabetes Treatment
Broad Street Alerts - PharmaCyte Biotech Investor Update: Revolutionizing Potential Diabetes Treatment PR Newswire
27.10.15 - PR Newswire
PharmaCyte Biotech Due Diligence Report - Technology Gets an Industry Boost - Small Cap Street
PharmaCyte Biotech Due Diligence Report - Technology Gets an Industry Boost - Small Cap Street PR Newswire
13.10.15 - PR Newswire
Investor Update: PharmaCyte Biotech Due Diligence Report - Small Cap Street
Investor Update: PharmaCyte Biotech Due Diligence Report - Small Cap Street PR Newswire
28.09.15 - PR Newswire
SHAREHOLDER UPDATE: PharmaCyte Biotech Starts the Path to Phase II Clinicals - Small Cap Street
SHAREHOLDER UPDATE: PharmaCyte Biotech Starts the Path to Phase II Clinicals - Small Cap Street PR Newswire
18.08.15 - PR Newswire
Small Cap Street Discovers Key Due Diligence on PharmaCyte Biotech
Small Cap Street Discovers Key Due Diligence on PharmaCyte Biotech PR Newswire
09.07.15 - PR Newswire
Small Cap IR Initiates Analyst Coverage - PharmaCyte Biotech Drug Delivery Platform Limited only by Imagination
Small Cap IR Initiates Analyst Coverage - PharmaCyte Biotech Drug Delivery Platform Limited only by Imagination PR Newswire
14.07.14 - PR Newswire
Nuvilex Analyst Report: Potentially Revolutionary Technology Positions Biopharmaceutical Firm as a Cancer Market Competitor - Fundamentals Need to Catch up With Expectations by BrokerBank Securities,
Nuvilex Analyst Report: Potentially Revolutionary Technology Positions Biopharmaceutical Firm as a Cancer Market Competitor - Fundamentals Need to Catch up With Expectations ...
15.04.14 - PR Newswire
Nuvilex, Inc. Analyst Report: Potentially Revolutionary Technology Positions Biopharmaceutical Firm as a Cancer Market Competitor - Fundamentals Need to Catch up With Expectations by Brokerbank Securi
Nuvilex, Inc. Analyst Report: Potentially Revolutionary Technology Positions Biopharmaceutical Firm as a Cancer Market Competitor - Fundamentals Need to Catch up With ...
06.03.14 - PR Newswire
Recent Events Effectively De-Risk Nuvilex, Inc.
Recent Events Effectively De-Risk Nuvilex, Inc. PR Newswire
26.02.14 - PR Newswire
Nuvilex Comprehensive Analyst Report Answers Vital Questions for Shareholders, by BrokerBank Securities, Inc.
Nuvilex Comprehensive Analyst Report Answers Vital Questions for Shareholders, by BrokerBank Securities, Inc. PR Newswire

Newssuche

Videos

09:30 Uhr +21,95%
Technical Trading: S&P 500 Short Chance
S&P 500 Short Typ: Turbo Open End WKN: NG8FUZ Hebel: 31 Laufzeit: OpenEnd Einstieg: Market ... Mehr »